Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIRRHF: Spironolactone vs Indapamide in Hypertension
NCT04455178Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in hypertension (HTN), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
spironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04455178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04455178.